Literature DB >> 24448023

MiR-144 regulates hematopoiesis and vascular development by targeting meis1 during zebrafish development.

Zhenhong Su1, Wenxia Si2, Lei Li2, Bisheng Zhou2, Xiuchun Li2, Yan Xu2, Chengqi Xu2, Haibo Jia2, Qing K Wang3.   

Abstract

Hematopoiesis is a dynamic process by which peripheral blood lineages are developed. It is a process tightly regulated by many intrinsic and extrinsic factors, including transcriptional factors and signaling molecules. However, the epigenetic regulation of hematopoiesis, for example, regulation via microRNAs (miRNAs), remains incompletely understood. Here we show that miR-144 regulates hematopoiesis and vascular development in zebrafish. Overexpression of miR-144 inhibited primitive hematopoiesis as demonstrated by a reduced number of circulating blood cells, reduced o-dianisidine staining of hemoglobin, and reduced expression of hbαe1, hbβe1, gata1 and pu.1. Overexpression of miR-144 also inhibited definitive hematopoiesis as shown by reduced expression of runx1 and c-myb. Mechanistically, miR-144 regulates hematopoiesis by repressing expression of meis1 involved in hematopoiesis. Both real-time RT-PCR and Western blot analyses showed that overexpression of miR-144 repressed expression of meis1. Bioinformatic analysis predicts a target binding sequence for miR-144 at the 3'-UTR of meis1. Deletion of the miR-144 target sequence eliminated the repression of meis1 expression mediated by miR-144. The miR-144-mediated abnormal phenotypes were partially rescued by co-injection of meis1 mRNA and could be almost completely rescued by injection of both meis1 and gata1 mRNA. Finally, because meis1 is involved in vascular development, we tested the effect of miR-144 on vascular development. Overexpression of miR-144 resulted in abnormal vascular development of intersegmental vessels in transgenic zebrafish with Flk1p-EGFP, and the defect was rescued by co-injection of meis1 mRNA. These findings establish miR-144 as a novel miRNA that regulates hematopoiesis and vascular development by repressing expression of meis1.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Meis1; MiR-144; Primitive and definitive hematopoiesis; Zebrafish (Danio rerio)

Mesh:

Substances:

Year:  2014        PMID: 24448023     DOI: 10.1016/j.biocel.2014.01.005

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  20 in total

1.  MicroRNA-144 targets APP to regulate AML1/ETO+ leukemia cell migration via the p-ERK/c-Myc/MMP-2 pathway.

Authors:  Ling Jiang; Wei Meng; Guopan Yu; Changxin Yin; Zhixiang Wang; Libin Liao; Fanyi Meng
Journal:  Oncol Lett       Date:  2019-06-14       Impact factor: 2.967

2.  Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies.

Authors:  Hongmei Zhu; Siu Wai Leung
Journal:  Diabetologia       Date:  2015-02-13       Impact factor: 10.122

3.  Identification of a new adtrp1-tfpi regulatory axis for the specification of primitive myelopoiesis and definitive hematopoiesis.

Authors:  Li Wang; Xiaojing Wang; Longfei Wang; Muhammad Yousaf; Jia Li; Mengxia Zuo; Zhongcheng Yang; Dongzhi Gou; Binghao Bao; Lei Li; Ning Xiang; Haibo Jia; Chengqi Xu; Qiuyun Chen; Qing Kenneth Wang
Journal:  FASEB J       Date:  2017-09-06       Impact factor: 5.191

Review 4.  MicroRNA aberrations: An emerging field for gallbladder cancer management.

Authors:  Vishal Chandra; Jong Joo Kim; Balraj Mittal; Rajani Rai
Journal:  World J Gastroenterol       Date:  2016-02-07       Impact factor: 5.742

5.  Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcription.

Authors:  Chunyan Luo; Elisabeth Pook; Bo Tang; Weiyi Zhang; Sisi Li; Kirsten Leineweber; Shing-Hu Cheung; Qiuyun Chen; Martin Bechem; Jing-Shan Hu; Volker Laux; Qing Kenneth Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-20       Impact factor: 5.187

6.  Transcription factor Meis1 act as a new regulator of ischemic arrhythmias in mice.

Authors:  Yining Liu; Jiamin Li; Ning Xu; Hang Yu; Liling Gong; Qingsui Li; Zhenyu Yang; Sijia Li; Jiming Yang; Di Huang; Yadong Xue; Genlong Xue; Jiali Liu; Haixin Chen; Ruijie Zhang; Anqi Li; Yiming Zhao; PengYu Li; Ming Li; Mingbin Liu; Ning Wang; Benzhi Cai
Journal:  J Adv Res       Date:  2021-11-15       Impact factor: 12.822

7.  Single and Compound Knock-outs of MicroRNA (miRNA)-155 and Its Angiogenic Gene Target CCN1 in Mice Alter Vascular and Neovascular Growth in the Retina via Resident Microglia.

Authors:  Lulu Yan; Sangmi Lee; Douglas R Lazzaro; Jacob Aranda; Maria B Grant; Brahim Chaqour
Journal:  J Biol Chem       Date:  2015-08-04       Impact factor: 5.157

8.  phlda3 overexpression impairs specification of hemangioblasts and vascular development.

Authors:  Xiaojing Wang; Jia Li; Zhongcheng Yang; Li Wang; Lei Li; Wenqing Deng; Juan Zhou; Longfei Wang; Chengqi Xu; Qiuyun Chen; Qing K Wang
Journal:  FEBS J       Date:  2018-09-20       Impact factor: 5.542

9.  Cardiac sodium channel regulator MOG1 regulates cardiac morphogenesis and rhythm.

Authors:  Juan Zhou; Longfei Wang; Mengxia Zuo; Xiaojing Wang; Abu Shufian Ishtiaq Ahmed; Qiuyun Chen; Qing K Wang
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

10.  The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144.

Authors:  Heng Cai; Yixue Xue; Ping Wang; Zhenhua Wang; Zhen Li; Yi Hu; Zhiqing Li; Xiuli Shang; Yunhui Liu
Journal:  Oncotarget       Date:  2015-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.